These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22135073)

  • 1. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
    Prabhakaran S; McNulty M; O'Neill K; Ouyang B
    Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.
    Rajamani K; Millis S; Watson S; Mada F; Salowich-Palm L; Hinton S; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):49-54. PubMed ID: 21852156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
    Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
    JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States trends in thrombolysis for older adults with acute ischemic stroke.
    George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
    Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Stroke Center Certification on Thrombolysis Time Metrics in Telestroke Setting.
    Almallouhi E; Ajinkya S; Rahwan M; Holmstedt CA; Al Kasab S
    Telemed J E Health; 2021 Feb; 27(2):167-171. PubMed ID: 32397843
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.
    Man S; Zhao X; Uchino K; Hussain MS; Smith EE; Bhatt DL; Xian Y; Schwamm LH; Shah S; Khan Y; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004512. PubMed ID: 29794035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.
    Mullen MT; Kasner SE; Kallan MJ; Kleindorfer DO; Albright KC; Carr BG
    J Am Heart Assoc; 2013 Mar; 2(2):e000071. PubMed ID: 23537806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.